Oncoclínicas do Brasil Serviços Médicos S.A.

BOVESPA:ONCO3 Voorraadrapport

Marktkapitalisatie: R$2.8b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Oncoclínicas do Brasil Serviços Médicos Balans Gezondheid

Financiële gezondheid criteriumcontroles 1/6

Oncoclínicas do Brasil Serviços Médicos heeft een totaal eigen vermogen van R$4.2B en een totale schuld van R$5.2B, wat de schuld-eigenvermogensverhouding op 124.5% brengt. De totale activa en totale passiva bedragen respectievelijk R$12.1B en R$8.0B. De EBIT Oncoclínicas do Brasil Serviços Médicos is R$755.6M waardoor de rentedekking 1.5 is. Het heeft contanten en kortetermijnbeleggingen van R$2.3B.

Belangrijke informatie

124.5%

Verhouding schuld/eigen vermogen

R$5.18b

Schuld

Rente dekkingsratio1.5x
ContantR$2.29b
AandelenR$4.16b
Totaal verplichtingenR$7.95b
Totaal activaR$12.11b

Recente financiële gezondheidsupdates

Recent updates

With A 25% Price Drop For Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) You'll Still Get What You Pay For

Sep 27
With A 25% Price Drop For Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) You'll Still Get What You Pay For

Here's What Analysts Are Forecasting For Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) After Its Second-Quarter Results

Aug 15
Here's What Analysts Are Forecasting For Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) After Its Second-Quarter Results

Oncoclínicas do Brasil Serviços Médicos (BVMF:ONCO3) Takes On Some Risk With Its Use Of Debt

Aug 13
Oncoclínicas do Brasil Serviços Médicos (BVMF:ONCO3) Takes On Some Risk With Its Use Of Debt

Earnings Tell The Story For Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) As Its Stock Soars 27%

Jul 16
Earnings Tell The Story For Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) As Its Stock Soars 27%

Is Now An Opportune Moment To Examine Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3)?

Jul 03
Is Now An Opportune Moment To Examine Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3)?

Investors Appear Satisfied With Oncoclínicas do Brasil Serviços Médicos S.A.'s (BVMF:ONCO3) Prospects As Shares Rocket 25%

Jun 01
Investors Appear Satisfied With Oncoclínicas do Brasil Serviços Médicos S.A.'s (BVMF:ONCO3) Prospects As Shares Rocket 25%

Oncoclínicas do Brasil Serviços Médicos S.A.'s (BVMF:ONCO3) Share Price Is Still Matching Investor Opinion Despite 27% Slump

Apr 17
Oncoclínicas do Brasil Serviços Médicos S.A.'s (BVMF:ONCO3) Share Price Is Still Matching Investor Opinion Despite 27% Slump

Oncoclínicas do Brasil Serviços Médicos' (BVMF:ONCO3) Earnings Are Weaker Than They Seem

Apr 03
Oncoclínicas do Brasil Serviços Médicos' (BVMF:ONCO3) Earnings Are Weaker Than They Seem

Oncoclínicas do Brasil Serviços Médicos (BVMF:ONCO3) Has A Somewhat Strained Balance Sheet

Mar 11
Oncoclínicas do Brasil Serviços Médicos (BVMF:ONCO3) Has A Somewhat Strained Balance Sheet

What Does Oncoclínicas do Brasil Serviços Médicos S.A.'s (BVMF:ONCO3) Share Price Indicate?

Feb 17
What Does Oncoclínicas do Brasil Serviços Médicos S.A.'s (BVMF:ONCO3) Share Price Indicate?

It's A Story Of Risk Vs Reward With Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3)

Dec 08
It's A Story Of Risk Vs Reward With Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3)

Why Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) Could Be Worth Watching

Nov 06
Why Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) Could Be Worth Watching

Is Now The Time To Put Oncoclínicas do Brasil Serviços Médicos (BVMF:ONCO3) On Your Watchlist?

Sep 11
Is Now The Time To Put Oncoclínicas do Brasil Serviços Médicos (BVMF:ONCO3) On Your Watchlist?

Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) Just Reported Earnings, And Analysts Cut Their Target Price

Apr 03
Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) Just Reported Earnings, And Analysts Cut Their Target Price

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( R$5.0B ) ONCO3 } overtreffen de korte termijn passiva ( R$2.5B ).

Langlopende schulden: De kortetermijnactiva van ONCO3 ( R$5.0B ) dekken de langetermijnschulden ( R$5.4B ) niet.


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 69.5% ) ONCO3 wordt als hoog beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van ONCO3 is de afgelopen 5 jaar gestegen van 109.3% naar 124.5%.

Schuldendekking: De operationele kasstroom van ONCO3 is negatief, waardoor de schuld niet goed gedekt is.

Rentedekking: De rentebetalingen van ONCO3 op haar schulden worden niet goed gedekt door EBIT ( 1.5 x dekking).


Balans


Ontdek gezonde bedrijven